On September 24, 2019, Advisory Board hosted its first-ever Cross-Industry Value Summit. Why? We think “value” may be the most overused yet least agreed upon term in our health care lexicon. On the surface, most stakeholders align on an aspirational definition of value: the right treatment for the right patient in the right setting at the right time. But all too often, legacy mistrust, siloed perspectives, and competing incentives impede the advancement of common definitions or shared frameworks for truly assessing value in U.S. health care.
In an effort to break down industry barriers and encourage more honest dialogue, this invite-only event convened 40 medical and pharmacy leaders from across the health care ecosystem—payers, providers, employers as well as third party “technology assessment” organizations increasingly opining on the value of new treatments.
Experts featured at our 2019 Cross-Industry Value Summit included:
I thoroughly enjoyed the Summit—it was great to connect with folks across different fields within health care, hear from a variety of experts on how they are thinking about creating value for patients, and reshaping how we approach health and engagement.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.